These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 10206087)

  • 21. Clevidipine for acute hypertension in patients with subarachnoid hemorrhage: a pilot study.
    Varelas PN; Abdelhak T; Corry JJ; James E; Rehman MF; Schultz L; Mays-Wilson K; Mitsias P
    Int J Neurosci; 2014 Mar; 124(3):192-8. PubMed ID: 24007334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, in man. A study using a stable isotope techique.
    Heikkinen H; Saraheimo M; Antila S; Ottoila P; Pentikäinen PJ
    Eur J Clin Pharmacol; 2001; 56(11):821-6. PubMed ID: 11294372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coronary and systemic hemodynamic effects of clevidipine, an ultra-short-acting calcium antagonist, for treatment of hypertension after coronary artery surgery.
    Kieler-Jensen N; Jolin-Mellgård A; Nordlander M; Ricksten SE
    Acta Anaesthesiol Scand; 2000 Feb; 44(2):186-93. PubMed ID: 10695913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro hydrolysis rate and protein binding of clevidipine, a new ultrashort-acting calcium antagonist metabolised by esterases, in different animal species and man.
    Ericsson H; Tholander B; Regårdh CG
    Eur J Pharm Sci; 1999 Apr; 8(1):29-37. PubMed ID: 10072476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clevidipine, an intravenous dihydropyridine calcium channel blocker, is safe and effective for the treatment of patients with acute severe hypertension.
    Pollack CV; Varon J; Garrison NA; Ebrahimi R; Dunbar L; Peacock WF
    Ann Emerg Med; 2009 Mar; 53(3):329-38. PubMed ID: 18534716
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics.
    Schüttler J; Eisenried A; Lerch M; Fechner J; Jeleazcov C; Ihmsen H
    Anesthesiology; 2020 Apr; 132(4):636-651. PubMed ID: 31972655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of clevidipine butyrate in the treatment of acute hypertension in the critical care setting: a review.
    Awad AS; Goldberg ME
    Vasc Health Risk Manag; 2010 Aug; 6():457-64. PubMed ID: 20730061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clevidipine in acute heart failure: Results of the A Study of Blood Pressure Control in Acute Heart Failure-A Pilot Study (PRONTO).
    Peacock WF; Chandra A; Char D; Collins S; Der Sahakian G; Ding L; Dunbar L; Fermann G; Fonarow GC; Garrison N; Hu MY; Jourdain P; Laribi S; Levy P; Möckel M; Mueller C; Ray P; Singer A; Ventura H; Weiss M; Mebazaa A
    Am Heart J; 2014 Apr; 167(4):529-36. PubMed ID: 24655702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SC-52458, an orally active angiotensin II-receptor antagonist: inhibition of blood pressure response to angiotensin II challenges and pharmacokinetics in normal volunteers.
    Hagmann M; Nussberger J; Naudin RB; Burns TS; Karim A; Waeber B; Brunner HR
    J Cardiovasc Pharmacol; 1997 Apr; 29(4):444-50. PubMed ID: 9156352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Calcium antagonist protects the myocardium from reperfusion injury by interfering with mechanisms directly related to reperfusion: an experimental study with the ultrashort-acting calcium antagonist clevidipine.
    Segawa D; Sjöquist PO; Wang QD; Gonon A; Nordlander M; Rydén L
    J Cardiovasc Pharmacol; 2000 Sep; 36(3):338-43. PubMed ID: 10975591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics and tissue distribution study of clevidipine and its primary metabolite H152/81 in rats.
    Wang Y; Zhao L; Li T; Yang W; Li Q; Sun L; Ding L
    Biomed Chromatogr; 2018 Feb; 32(2):. PubMed ID: 28707762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and pharmacodynamics of tezosentan, an intravenous dual endothelin receptor antagonist, following chronic infusion in healthy subjects.
    Dingemanse J; Clozel M; van Giersbergen PL
    Br J Clin Pharmacol; 2002 Apr; 53(4):355-62. PubMed ID: 11966665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and pharmacodynamic effects of the angiotensin II antagonist valsartan at steady state in healthy, normotensive subjects.
    Müller P; Flesch G; de Gasparo M; Gasparini M; Howald H
    Eur J Clin Pharmacol; 1997; 52(6):441-9. PubMed ID: 9342579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perioperative Use of Clevidipine: A Systematic Review and Meta-Analysis.
    Espinosa A; Ripollés-Melchor J; Casans-Francés R; Abad-Gurumeta A; Bergese SD; Zuleta-Alarcon A; López-Timoneda F; Calvo-Vecino JM;
    PLoS One; 2016; 11(3):e0150625. PubMed ID: 27018586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and pharmacodynamics of flestolol, a new short-acting, beta-adrenergic receptor antagonist.
    Achari R; Drissel D; Hulse JD; Bell V; Turlapaty P; Laddu A; Matier WL
    J Clin Pharmacol; 1987 Jan; 27(1):60-4. PubMed ID: 2890664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.
    Luzier AB; Killian A; Wilton JH; Wilson MF; Forrest A; Kazierad DJ
    Clin Pharmacol Ther; 1999 Dec; 66(6):594-601. PubMed ID: 10613615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clevidipine : a state-of-the-art antihypertensive drug under the scope.
    Espina IM; Varon J
    Expert Opin Pharmacother; 2012 Feb; 13(3):387-93. PubMed ID: 22251017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clevidipine compared with nitroglycerin for blood pressure control in coronary artery bypass grafting: a randomized double-blind study.
    Merry AF; Avery EG; Nussmeier NA; Playford HR; Warman GR; Wang Y; Sladen RN
    Can J Anaesth; 2014 May; 61(5):398-406. PubMed ID: 24700403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics, safety, and tolerability of single intravenous infusions of an adenosine agonist, AMP 579, in healthy male volunteers.
    Zannikos PN; Baybutt RI; Boutouyrie BX; Shah B; Hunt TL; Jensen BK
    J Clin Pharmacol; 1999 Oct; 39(10):1044-52. PubMed ID: 10516939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effect of Clevidipine on Cerebral Blood Flow Velocity and Carbon Dioxide Reactivity in Human Volunteers.
    Lemkuil BP; Gierl BT; Patel PM; Pearn ML; Nguyen LC; Minokadeh A; Drummond JC
    J Neurosurg Anesthesiol; 2016 Oct; 28(4):337-40. PubMed ID: 26447497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.